Levels of human equilibrative nucleoside transporter-1 are higher in proliferating regions of A549 tumor cells grown as tumor xenografts in vivo.

[1]  M. Huizing,et al.  Retro-orbital injections in mice , 2011, Lab Animal.

[2]  K. Krohn,et al.  Different Modes of Transport for 3H-Thymidine, 3H-FLT, and 3H-FMAU in Proliferating and Nonproliferating Human Tumor Cells , 2010, The Journal of Nuclear Medicine.

[3]  M. Wuest,et al.  Biodistribution and Uptake of 3′-Deoxy-3′-Fluorothymidine in ENT1-Knockout Mice and in an ENT1-Knockdown Tumor Model , 2010, The Journal of Nuclear Medicine.

[4]  Carol Cass,et al.  Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer , 2010, Journal of cellular physiology.

[5]  C. Cass,et al.  Predicting gemcitabine transport and toxicity in human pancreatic cancer cell lines with the positron emission tomography tracer 3'-deoxy-3'-fluorothymidine. , 2010, Biochemical pharmacology.

[6]  S. Shousha,et al.  Altered Tissue 3′-Deoxy-3′-[18F]Fluorothymidine Pharmacokinetics in Human Breast Cancer following Capecitabine Treatment Detected by Positron Emission Tomography , 2009, Clinical Cancer Research.

[7]  S. Yao,et al.  The Role of Human Nucleoside Transporters in Uptake of 3′-Deoxy-3′-fluorothymidine , 2008, Molecular Pharmacology.

[8]  Mette Jensen,et al.  Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by 18F-FDG-microPET or external caliper , 2008, BMC Medical Imaging.

[9]  M. Monden,et al.  Human equilibrative nucleoside transporter 1, as a predictor of 5-fluorouracil resistance in human pancreatic cancer. , 2007, Anticancer research.

[10]  H. Barthel,et al.  Redistribution of nucleoside transporters to the cell membrane provides a novel approach for imaging thymidylate synthase inhibition by positron emission tomography. , 2006, Cancer research.

[11]  U Creutzig,et al.  The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia , 2005, British Journal of Cancer.

[12]  K. Krohn,et al.  Effect of p53 activation on cell growth, thymidine kinase-1 activity, and 3'-deoxy-3'fluorothymidine uptake. , 2004, Nuclear medicine and biology.

[13]  L. Wiens,et al.  Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  Torsten Mattfeldt,et al.  3-deoxy-3-[(18)F]fluorothymidine-positron emission tomography for noninvasive assessment of proliferation in pulmonary nodules. , 2002, Cancer research.

[15]  Ying Zhang,et al.  PKC regulation of the human equilibrative nucleoside transporter, hENT1 , 2002, FEBS letters.

[16]  Johannes Gerdes,et al.  The Ki‐67 protein: From the known and the unknown , 2000, Journal of cellular physiology.

[17]  C. Cass,et al.  Fluctuations in nucleoside uptake and binding of the inhibitor of nucleoside transport, nitrobenzylthioinosine, during the replication cycle of HeLa cells. , 1979, Cancer research.